HER2 regulates cancer stem-like cell phenotype in ALK translocated NSCLC
CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma. - Abstract - Europe PMC
Jinfukang induces cellular apoptosis through activation of Fas and DR4 in A549 cells
AddexBio Product Detail - A431 Cells
Evaluation of EML4-ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors. - Abstract - Europe PMC
NCI-H2228 Cell Line - EP-CL-0570 | Civic Bioscience
Establishment of ALK-TKI-resistant H2228 cells. (A) H2228-CRR,... | Download Scientific Diagram
The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1 | Oncogenesis
Cell Lines Nci H2228 (ATCC) | Bioz | Ratings For Life-Science Research
Vulnerability of drug‐resistant EML4‐ALK rearranged lung cancer to transcriptional inhibition | EMBO Molecular Medicine
Figure 3. | Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases | Cancer Research
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer - ScienceDirect
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer - ScienceDirect
![PDF] Receptor ligand-triggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4-ALK lung cancer cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2b265c0fd1b06a512472598fe7575a0e724931a3/2-Figure1-1.png "PDF] Receptor ligand-triggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4-ALK lung cancer cells | Semantic Scholar")
PDF] Receptor ligand-triggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4-ALK lung cancer cells | Semantic Scholar
Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncology | Future Oncology
HUMAN IMPRINTING ENCYCLOPEDIA
PLOS ONE: Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3
Epithelial‐mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4‐ALK translocation - Kim - 2013 - Molecular Oncology - Wiley Online Library
Effect of PF-02341066 and radiation on non-small cell lung cancer cells
HGF-gene transfection resulted in reducing susceptibility of EML4-ALK... | Download Scientific Diagram
Sensitivities to ALK inhibitors (crizotinib and alectinib) in... | Download Scientific Diagram
Epithelial‐mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4‐ALK translocation - Kim - 2013 - Molecular Oncology - Wiley Online Library
Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1 | Cell Death & Disease
A549/DDP Cell Line - EP-CL-0519 | Civic Bioscience
Cells | Free Full-Text | Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement | HTML
